IDEAYA Biosciences, Inc. (FRA:30J)
31.00
-1.20 (-3.73%)
Last updated: Jan 9, 2026, 8:02 AM CET
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of €2.82 billion as of January 9, 2026. Its market cap has increased by 33.53% in one year.
Market Cap
2.82B
Enterprise Value
1.86B
Revenue
183.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€31.00
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from 193.04M to 2.82B, an increase of 1,359.39%. That is a compound annual growth rate of 49.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.82B | 9.14% |
| Dec 31, 2025 | 2.58B | 20.30% |
| Dec 31, 2024 | 2.15B | 3.41% |
| Dec 29, 2023 | 2.07B | 153.65% |
| Dec 30, 2022 | 818.01M | 2.24% |
| Dec 31, 2021 | 800.08M | 140.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |